1. Home
  2. PLYM vs VIR Comparison

PLYM vs VIR Comparison

Compare PLYM & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLYM
  • VIR
  • Stock Information
  • Founded
  • PLYM 2011
  • VIR 2016
  • Country
  • PLYM United States
  • VIR United States
  • Employees
  • PLYM N/A
  • VIR N/A
  • Industry
  • PLYM Real Estate Investment Trusts
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLYM Real Estate
  • VIR Health Care
  • Exchange
  • PLYM Nasdaq
  • VIR Nasdaq
  • Market Cap
  • PLYM 794.4M
  • VIR 844.9M
  • IPO Year
  • PLYM 2017
  • VIR 2019
  • Fundamental
  • Price
  • PLYM $15.57
  • VIR $5.41
  • Analyst Decision
  • PLYM Buy
  • VIR Strong Buy
  • Analyst Count
  • PLYM 9
  • VIR 7
  • Target Price
  • PLYM $21.44
  • VIR $33.57
  • AVG Volume (30 Days)
  • PLYM 392.8K
  • VIR 1.0M
  • Earning Date
  • PLYM 05-01-2025
  • VIR 05-07-2025
  • Dividend Yield
  • PLYM 6.14%
  • VIR N/A
  • EPS Growth
  • PLYM 600.05
  • VIR N/A
  • EPS
  • PLYM 3.05
  • VIR N/A
  • Revenue
  • PLYM $180,505,000.00
  • VIR $20,861,000.00
  • Revenue This Year
  • PLYM $4.40
  • VIR N/A
  • Revenue Next Year
  • PLYM $8.36
  • VIR $10.65
  • P/E Ratio
  • PLYM $5.13
  • VIR N/A
  • Revenue Growth
  • PLYM N/A
  • VIR N/A
  • 52 Week Low
  • PLYM $12.70
  • VIR $4.95
  • 52 Week High
  • PLYM $24.71
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • PLYM 57.44
  • VIR 35.98
  • Support Level
  • PLYM $15.05
  • VIR $5.83
  • Resistance Level
  • PLYM $15.73
  • VIR $6.29
  • Average True Range (ATR)
  • PLYM 0.41
  • VIR 0.31
  • MACD
  • PLYM 0.19
  • VIR 0.02
  • Stochastic Oscillator
  • PLYM 89.87
  • VIR 28.80

About PLYM Plymouth Industrial REIT Inc.

Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: